![Andrew Grethlein](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Andrew Grethlein
Plus aucun poste en cours
Fortune : - $ au 30/06/2026
Profil
Andrew J.
Grethlein worked as Manager-Biologics Development & Manufacturing at Athena Neurosciences LLC from 1995 to 1997.
From 1997 to 2003, served as Senior Director-South San Francisco Pharmaceutical at Elan Corp.
Plc.
Held the position of Senior Vice President-Pharmaceutical Operations at Tercica, Inc. from 2003 to 2008.
From 2008 to 2010, was Senior Vice President-Hematology at Ipsen SA. Served as Chief Operating Officer & Executive Vice President at Inspiration Biopharmaceuticals, Inc. from 2010 to 2012.
Worked as Principal at Ipsen International GmbH.
From 2019 to 2025, held the role of Chief Operating Officer & Executive Vice President at Geron Corp.
Education includes undergraduate degrees from Bard College at Simon's Rock and Bates College, and graduate and doctorate degrees from Michigan State University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
GERON CORPORATION -.--% | 26/03/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Anciens postes connus de Andrew Grethlein
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Directeur des opérations | 15/10/2025 |
Inspiration Biopharmaceuticals, Inc.
 Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Directeur des opérations | 01/09/2012 |
| IPSEN | Corporate Officer/Principal | 01/01/2010 |
Tercica, Inc.
 Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Corporate Officer/Principal | - |
Elan Corp. Plc
 Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Corporate Officer/Principal | 01/01/2003 |
Formation de Andrew Grethlein
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
70
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Elan Corp. Plc
Elan Corp. Plc Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals and drug delivery systems | Health Technology |
Athena Neurosciences LLC
 Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic products | Commercial Services |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Tercica, Inc.
Tercica, Inc. Pharmaceuticals: MajorHealth Technology Develops new therapeutics for endocrine system disorders | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Inspiration Biopharmaceuticals, Inc.
Inspiration Biopharmaceuticals, Inc. Medical SpecialtiesHealth Technology Produces intravenous recombinant therapies and develops non-invasive applications | Health Technology |
Michigan State University
 Michigan State University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ipsen International GmbH
 Ipsen International GmbH Industrial MachineryProducer Manufacturing Manufactures and distributes furnaces and plant systems | Producer Manufacturing |
Bates College
 Bates College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Bard College at Simon's Rock
 Bard College at Simon's Rock Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
